ALPP yields 285714.29% · MRK yields 2.76%● Live data
📍 ALPP pulled ahead of the other in Year 1
Combined, ALPP + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ALPP + MRK for your $10,000?
Alpine 4 Holdings, Inc. a technology holding company, provides electronic contract manufacturing solutions in the United States. The company also offers automotive technologies, including 6th Sense Auto, a connected car technology that provides various advantages to management, sales, finance, and service departments in the automotive dealership industry to enhance productivity, profitability, and customer retention; and BrakeActive, a safety device that enhances vehicle's third brake light's ability to reduce or prevent a rear-end collision. In addition, it designs, fabricates, and installs dust collectors, commercial ductwork, kitchen hoods, industrial ventilation systems, machine guards, architectural work, water furnaces, and other products, as well as offers specialized spiral ductwork. Further, the company provides logistics services for various industries, such as medical, consumer electronics, energy, and disaster relief; contract manufacturing services for dietary and nutritional supplements; international contracting, fabricator, and project management services; and geospatial and 3D data services for various industries, including construction, oil/gas, mining, and quarries. It also manufacturers and sells electronic components; and designs, manufactures, and distributes commercial LED lighting and electronics, such as televisions, mounting solutions, projectors and screens, audio equipment, digital signage, mobile audio and video systems, and various wire and connecting products. The company was formerly known as Alpine 4 Technologies, Ltd. and changed its name to Alpine 4 Holdings, Inc. in March 2021. Alpine 4 Holdings, Inc. was incorporated in 2014 and is based in Phoenix, Arizona.
Full ALPP Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.